Celldex Therapeutics
CLDX
$40.86
Share price
3.84%
Change (1 day)
32.45%
Change (1 year)
Categories
Celldex Therapeutics (CLDX) - Total assets
Total assets on the balance sheet as of December 2023 : $0.46 B
According to Celldex Therapeutics's latest financial reports the company's total assets are $0.46 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Celldex Therapeutics - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.46 B | 32% |
| 2022-12-31 | $0.35 B | -20.67% |
| 2021-12-31 | $0.44 B | 88.54% |
| 2020-12-31 | $0.23 B | 91.84% |
| 2019-12-31 | $0.12 B | -21.1% |
| 2018-12-31 | $0.15 B | -50.63% |
| 2017-12-31 | $0.31 B | -17.67% |
| 2016-12-31 | $0.38 B | 13.56% |
| 2015-12-31 | $0.33 B | 36.11% |
| 2014-12-31 | $0.24 B | -28.55% |
| 2013-12-31 | $0.34 B | 176.48% |
| 2012-12-31 | $0.12 B | 28.11% |
| 2011-12-31 | $97.99 M | -10.87% |
| 2010-12-31 | $0.10 B | -21.67% |
| 2009-12-31 | $0.14 B | 101.11% |
| 2008-12-31 | $69.79 M | 644.5% |
| 2007-12-31 | $9.37 M | -84.75% |
| 2006-12-31 | $61.47 M | 68.66% |
| 2005-12-31 | $36.45 M | -20.42% |
| 2004-12-31 | $45.8 M | 46.31% |
| 2003-12-31 | $31.3 M | -11.15% |
| 2002-12-31 | $35.23 M | -34.12% |
| 2001-12-31 | $53.48 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $226.50 B | 48,544.30% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 20,765.20% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.11 B | 16,031.67% | 🇬🇧 UK |
 Titan Pharmaceuticals
TTNP | $8.08 M | -98.26% | 🇺🇸 USA |
 Seagen
SGEN | $3.63 B | 680.51% | 🇺🇸 USA |
 Agenus
AGEN | $0.31 B | -32.58% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $1.82 B | 291.56% | 🇺🇸 USA |